Answers are grounded in this paper and cite their sources.
This study aimed compare efficacy of edoxaban and enoxaparin upon biomarkers of hypercoagulability in patients with cancer-related embolic stroke of undetermined source (ESUS).
No takes yet. Share an insight, caveat, or question.
Chung et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: